Optimal timing of cardiac transplantation after ventricular assist device implantation  James S Gammie, MD, Leah B Edwards, PhD, Bartley P Griffith, MD, Richard N Pierson, MD, Lana Tsao, MD  The Journal of Thoracic and Cardiovascular Surgery  Volume 127, Issue 6, Pages 1789-1799 (June 2004) DOI: 10.1016/j.jtcvs.2003.12.018

Figure 1 Type of VAD. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1789-1799DOI: (10.1016/j.jtcvs.2003.12.018)

Figure 2 Effect of time between VAD implantation and transplantation on posttransplantation mortality. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1789-1799DOI: (10.1016/j.jtcvs.2003.12.018)

Figure 3 Effect of recipient serum creatinine and total bilirubin levels on posttransplantation mortality. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1789-1799DOI: (10.1016/j.jtcvs.2003.12.018)

Figure 4 Death or removal from the transplantation list during VAD support. *Days of device support, or days since listing if device implanted prior to listing. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1789-1799DOI: (10.1016/j.jtcvs.2003.12.018)

Figure 5 Outcomes on the waiting list for patients with a VAD at listing: adult waiting-list additions from October 25, 1999, to December 31, 2001. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 1789-1799DOI: (10.1016/j.jtcvs.2003.12.018)